Growth Opportunities and Trends in the Anti-Rabies Serum Market: Key Insights for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Will the CAGR of the Anti-Rabies Serum Market Influence Its Overall Growth by 2034?
Over the past few years, there has been substantial growth in the anti-rabies serum market size. The market is expected to enlarge from $1.42 billion in 2024 to $1.5 billion in 2025, with a compound annual growth rate (CAGR) of 5.7%. The growth during the historical period is due to several factors, including an increase in animal populations, extended vaccination programs, advances in diagnostic methods, augmentation in travel and emigration, as well as heightened public health measures and a surge in wildlife encounters.
Strong expansion is predicted for the anti-rabies serum market in the upcoming years, with it expected to reach $1.85 billion by 2029, furthering at a CAGR (compound annual growth rate) of 5.4%. This anticipated growth during the forecast period can be credited to increasing cases of animal bites, a rise in financial support for rabies studies, growing consciousness about illnesses transmitted from animals, advancements in handling and storage of serum, and escalated backing for rabies control initiatives. Key trends to follow in this forecast period are the innovation of new serum preparations, evolvements in the healthcare infrastructure, technological growth in serum manufacturing, the emergence of different delivery systems, and the creation of accelerated diagnostic kits.
What Market Dynamics Are Playing a Key Role in Accelerating the Growth of the Anti-Rabies Serum Market?
The anti-rabies serum market seems to be on track for more substantial growth due to the increasing occurrence of dog bites. The references here are to hurt or damage caused to humans by dogs either by biting or scratching, which could range from minor to severe. Dog bites have the potential to cause serious infections, wounds and transmission of diseases including rabies in a few instances. Prompt medical care and effective prevention are key to managing and lessening the risks of dog bites. This increment in dog bites occurrences is attributed to a multitude of reasons such as the escalated level of urbanization leading to increased contact between humans and dogs, the presence of a larger number of poorly trained or unrestrained dogs, and deficient awareness or knowledge regarding dog behavior and bite prevention methods. Consequently, there has been a similar rise in demand for anti-rabies serum since its timely administration is vital to prevent the development of rabies in those exposed to potentially infected animals. For example, in 2023, the American Veterinary Medical Association, a non-profit organization based in the US, reported that the average cost of dog bite insurance claims was $58,545. Insurers had to pay $1.12B in liability claims related to dog bites and other dog-related injuries that year, marking a nearly 10% increase in dog bite claims. As a result, this increased prevalence of dog bites is fuelling the growth of the anti-rabies serum market.
Explore Comprehensive Insights Into The Global Anti-Rabies Serum Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20468&type=smp
Who Are the Leading Companies Pioneering Change in the Anti-Rabies Serum Market?
Major companies operating in the anti-rabies serum market are:
• Merck & Co Inc._x000D_
• Sanofi SA_x000D_
• GlaxoSmithKline PLC_x000D_
• Takeda Pharmaceutical Company Limited_x000D_
• HCX Pharmaceuticals LLP_x000D_
What Are the Most Significant Trends Transforming the Anti-Rabies Serum Market Today?
Leading firms in the anti-rabies serum market are engaging in strategic alliances to elevate product growth and extend their market influence. These alliances typically allow corporations to utilize each other’s talents and assets for joint benefits and prosperity. For example, in July 2023, the American biopharmaceutical company Kedrion S.p.A joined forces with Kamada, an Israeli biopharmaceutical company, to broaden the distribution of KEDRAB (Rabies Immune Globulin [Human]) in the United States. This synergistic relationship has proven essential in co-creating and obtaining licensing for the product in the US, as well as promoting awareness of the disease. Through this collaboration, they have been able to guard individuals from severe and potentially fatal conditions, following exposure to bites from rabid animals.
Secure Your Global Anti-Rabies Serum Market Report Now for Fast and Efficient Delivery!
https://www.thebusinessresearchcompany.com/report/anti-rabies-serum-global-market-report
What Are the Primary Segments of the Anti-Rabies Serum Market and Their Roles in Growth Dynamics?
The anti-rabies serum market covered in this report is segmented –
1) By Type: Human Anti-rabies Immunoglobulin, Equine Anti-rabies Immunoglobulin
2) By Dosage And Form: Vials, Prefilled Syringes
3) By Route of Administration: Intravenous, Intramuscular
4) By End User: Hospitals, Clinics, Veterinary Hospitals
Subsegments:
1) By Human Anti-Rabies Immunoglobulin: Monovalent Human Anti-Rabies Immunoglobulin, Polyvalent Human Anti-Rabies Immunoglobulin, Intramuscular Human Anti-Rabies Immunoglobulin, Intravenous Human Anti-Rabies Immunoglobulin, Freeze-Dried Human Anti-Rabies Immunoglobulin
2) By Equine Anti-Rabies Immunoglobulin: Freeze-Dried Equine Anti-Rabies Immunoglobulin, Liquid Equine Anti-Rabies Immunoglobulin, Monovalent Equine Anti-Rabies Immunoglobulin, Polyvalent Equine Anti-Rabies Immunoglobulin
Which Regions Are Leading the Charge in Anti-Rabies Serum Market Development?
North America was the largest region in the anti-rabies serum market in 2024. The regions covered in the anti-rabies serum market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Is the Definition of the Anti-Rabies Serum Market Impacting Future Growth?
Anti-rabies serum, also known as rabies immune globulin (RIG), refers to a medical treatment used to provide immediate passive immunity against the rabies virus. It is administered to individuals who have been exposed to the virus through bites or scratches from potentially rabid animals, typically in conjunction with the rabies vaccine. The serum contains antibodies that neutralize the virus, helping to prevent the onset of rabies, which is a fatal disease once symptoms appear.
Browse Through More Similar Reports By The Business Research Company:
Rabies Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/rabies-diagnostics-global-market-report
Animal Therapeutics And Diagnostics Global Market Report 2025
Anti-Inflammatory Therapeutics Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
